Introduction
Pulmonary arterial hypertension (PAH) is a rare condition in which increased pulmonary arterial resistance results in progressive right ventricular failure. Median survival in untreated idiopathic disease is <3 years and, although specific therapies are now available, it is still associated with reduced life expectancy. Sufferers may appear well at rest, even when cardiac output is critically limited, leading to diagnostic delay and a substantial associated medical and psychological morbidity.1
High-impact medical research has become dominated by fundamental science or the development of new interventions. However, the delivery of good clinical care is often centred in profoundly personal interactions that change outcomes for individuals very powerfully.2 Quality of life can be assessed by clinically relevant and applicable scoring systems3–5 and correlates with outcomes.6 Study of these qualitative aspects of healthcare, though central to clinical practice, is rarely accorded high impact, perhaps both because of its perceived immediate failure to generate a new therapeutic target, and also in the difficulty there is in precisely quantifying the impact that it has. Qualitative studies in pulmonary hypertension have nonetheless highlighted the challenges for patients of developing an understanding of their illness and of coping with its progression,7 and holistic care includes close attention to qualitative factors.8
Narrative analysis is a qualitative research discipline developing deeper understanding of (in the medical case) illness from unstructured subject-derived data. Narrative approaches have roles in developing key clinical skills in clinical practitioners,9 and narrative research and practice have an important place in clinical medicine.10–12 Clinical practice operates in a narrative environment in which evidence-based medicine is applied within the context of individual patient stories. However, applying results of narrative studies to clinical practice is more challenging; the impact can be felt by highlighting paradigms or assumptions that are made, often without conscious thought. The length of narratives and their examination by techniques such as thematic analysis do not lend themselves to linking of narratives to changes in management within an individual, and communicating key findings in a concise form is challenging.
We believed that a narrative approach would yield specific and valuable insights into the challenges and management of PAH. We took a new approach using interpretative observer-dependent creative writing to summarise narratives and present them as microstories. We believed creating microstories would generate a new way to analyse these narratives, and simultaneously make the narratives more accessible to others. These stories have revealed themselves to be remarkable for their ability to reveal and communicate experiences of illness that are fundamental to a deeper understanding of an individual’s changing circumstances. These stories were received well by the participants who inspired them and have proved to be a powerful initiator of conversation and the reflective sharing of meaningful experience in other patients, family members and clinical care teams.